title: Regulation of CDX4 gene transcription by HoxA9, HoxA10, the Mll-Ell oncogene and Shp2 during leukemogenesis.
abstract: Cdx and Hox proteins are homeodomain transcription factors that regulate hematopoiesis. Transcription of the HOX and CDX genes decreases during normal myelopoiesis, but is aberrantly sustained in leukemias with translocation or partial tandem duplication of the MLL1 gene. Cdx4 activates transcription of the HOXA9 and HOXA10 genes, and HoxA10 activates CDX4 transcription. The events that break this feedback loop, permitting a decreased Cdx4 expression during normal myelopoiesis, were previously undefined. In the current study, we find that HoxA9 represses CDX4 transcription in differentiating myeloid cells, antagonizing activation by HoxA10. We determine that tyrosine phosphorylation of HoxA10 impairs transcriptional activation of CDX4, but tyrosine phosphorylation of HoxA9 facilitates repression of this gene. As HoxA9 and HoxA10 are phosphorylated during myelopoiesis, this provides a mechanism for differentiation stage-specific Cdx4 expression. HoxA9 and HoxA10 are increased in cells expressing Mll-Ell, a leukemia-associated MLL1 fusion protein. We find that Mll-Ell induces a HoxA10-dependent increase in Cdx4 expression in myeloid progenitor cells. However, Cdx4 decreases in a HoxA9-dependent manner on exposure of Mll-Ell-expressing cells to differentiating cytokines. Leukemia-associated, constitutively active mutants of Shp2 block cytokine-induced tyrosine phosphorylation of HoxA9 and HoxA10. In comparison with myeloid progenitor cells that are expressing Mll-Ell alone, we find increased CDX4 transcription and Cdx4 expression in cells co-expressing Mll-Ell plus constitutively active Shp2. Increased Cdx4 expression is sustained on exposure of these cells to differentiating cytokines. Our results identify a mechanism for increased and sustained CDX4 transcription in leukemias co-overexpressing HoxA9 and HoxA10 in combination with constitutive activation of Shp2. This is clinically relevant, because MLL1 translocations and constitutive Shp2 activation co-exist in human myeloid leukemias.
authors.affiliation: Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
authors.forename: L
authors.initials: L
authors.lastname: Bei
authors.affiliation: 1] Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA [2] The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA [3] Jesse Brown VA Medical Center, Chicago, IL, USA.
authors.forename: C
authors.initials: C
authors.lastname: Shah
authors.affiliation: Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
authors.forename: H
authors.initials: H
authors.lastname: Wang
authors.affiliation: Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
authors.forename: W
authors.initials: W
authors.lastname: Huang
authors.affiliation: 1] Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA [2] The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA [3] Jesse Brown VA Medical Center, Chicago, IL, USA.
authors.forename: L C
authors.initials: LC
authors.lastname: Platanias
authors.affiliation: 1] Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA [2] The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA [3] Jesse Brown VA Medical Center, Chicago, IL, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Eklund